Search research articles
Contact Us
Filters
Showing results (1-10 of 211) with videos related to
Page
of 22
Sort By:
Der Nervenarzt
|
September 28, 2019
[Update on antithrombotic secondary prevention of ischemic stroke]
Martin Köhrmann, Christoph Kleinschnitz
Current Opinion in Critical Care
|
July 7, 2009
Hemicraniectomy for malignant middle cerebral artery infarction
Martin Köhrmann, Stefan Schwab
Stroke
|
March 17, 2009
Is it ethical to have a placebo arm in reperfusion trials in the 3- to 6-hour time window? No: time frame or time gain?
Martin Köhrmann, Stefan Schwab
Neurology
|
April 24, 2015
Author response
Bernd Kallmünzer, Martin Köhrmann
Neurological Research and Practice
|
September 10, 2021
Digital concepts in post-stroke care pathways: adding value and minimizing burden
Christoph Schöbel, Martin Köhrmann
The New England Journal of Medicine
|
December 14, 2011
Images in clinical medicine. Internal-carotid-artery dissection and cranial-nerve palsies
Elena Peltz, Martin Köhrmann
European Neurology
|
August 24, 2013
Reply: To PMID 23548890
Lorenz Breuer, Martin Köhrmann
Nature Clinical Practice. Neurology
|
June 7, 2007
MRI-based thrombolytic therapy in acute stroke: finally, the proof of concept by DEFUSE
Martin Köhrmann, Peter D Schellinger
Stroke
|
October 26, 2018
Intravenous Thrombolytic Therapy Remains the Basis and Mainstay of Revascularizing Therapy!
Peter D Schellinger, Martin Köhrmann
Circulation
|
January 5, 2012
Letter to the editor by Köhrmann and Schellinger regarding article, "Current status of endovascular stroke treatment"
Martin Köhrmann, Peter D Schellinger
Page
of 22
Search research articles
Search
Showing results (1-10 of 211) with videos related to
Sort By:
Page
of 22
Der Nervenarzt
|
September 28, 2019
[Update on antithrombotic secondary prevention of ischemic stroke]
Martin Köhrmann, Christoph Kleinschnitz
Current Opinion in Critical Care
|
July 7, 2009
Hemicraniectomy for malignant middle cerebral artery infarction
Martin Köhrmann, Stefan Schwab
Stroke
|
March 17, 2009
Is it ethical to have a placebo arm in reperfusion trials in the 3- to 6-hour time window? No: time frame or time gain?
Martin Köhrmann, Stefan Schwab
Neurology
|
April 24, 2015
Author response
Bernd Kallmünzer, Martin Köhrmann
Neurological Research and Practice
|
September 10, 2021
Digital concepts in post-stroke care pathways: adding value and minimizing burden
Christoph Schöbel, Martin Köhrmann
The New England Journal of Medicine
|
December 14, 2011
Images in clinical medicine. Internal-carotid-artery dissection and cranial-nerve palsies
Elena Peltz, Martin Köhrmann
European Neurology
|
August 24, 2013
Reply: To PMID 23548890
Lorenz Breuer, Martin Köhrmann
Nature Clinical Practice. Neurology
|
June 7, 2007
MRI-based thrombolytic therapy in acute stroke: finally, the proof of concept by DEFUSE
Martin Köhrmann, Peter D Schellinger
Stroke
|
October 26, 2018
Intravenous Thrombolytic Therapy Remains the Basis and Mainstay of Revascularizing Therapy!
Peter D Schellinger, Martin Köhrmann
Circulation
|
January 5, 2012
Letter to the editor by Köhrmann and Schellinger regarding article, "Current status of endovascular stroke treatment"
Martin Köhrmann, Peter D Schellinger
Page
of 22